Human rhinovirus C: A newly discovered human rhinovirus species by Lau, SKP et al.
Title Human rhinovirus C: A newly discovered human rhinovirusspecies
Author(s) Lau, SKP; Yip, CCY; Woo, PCY; Yuen, KY
Citation Emerging Health Threats Journal, 2010, v. 3 n. 1
Issued Date 2010
URL http://hdl.handle.net/10722/125115
Rights Creative Commons: Attribution 3.0 Hong Kong License
REVIEW
Human rhinovirus C: a newly discovered human
rhinovirus species
SKP Lau1,2,3,4, CCY Yip4, PCY Woo1,2,3,4, and K-Y Yuen1,2,3,4
1State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; 2Research Centre of Infection and
Immunology, The University of Hong Kong, Hong Kong, China; 3Carol Yu Center for Infection, The University of Hong Kong, Hong Kong,
China; and 4Department of Microbiology, The University of Hong Kong, Hong Kong, China
Correspondence
Dr SKP Lau or Professor PCY Woo,
Department of Microbiology,
The University of Hong Kong,
University Pathology Building,
Queen Mary Hospital, Hong Kong,
China.
E-mail: skplau@hkucc.hku.hk or
pcywoo@hkucc.hku.hk
Received 21 July 2009
Revised 10 September 2009
Accepted 4 October 2009
Although often ignored, human rhinoviruses (HRVs) are the most frequent causes of respiratory
tract infections (RTIs). A group of closely related novel rhinoviruses have recently been
discovered. Based on their unique phylogenetic position and distinct genomic features, they are
classified as a separate species, HRV-C. After their discovery, HRV-C viruses have been detected in
patients worldwide, with a reported prevalence of 1.4–30.9% among tested specimens. This
suggests that the species contribute to a significant proportion of RTIs that were unrecognized in
the past. HRV-C is also the predominant HRV species, often with a higher detection rate than
that of the two previously known species, HRV-A and HRV-B. HRV-C infections appear to peak in
fall or winter in most temperate or subtropical countries, but may predominate in the rainy
season in the tropics. In children, HRV-C is often associated with upper RTIs, with asthma
exacerbation and wheezing episodes being common complications. The virus has also been
detected in children with bronchitis, bronchiolitis, pneumonia, otitis media, sinusitis and
systemic infections complicated by pericarditis. As for adults, HRV-C has been associated with
more severe disease such as pneumonia and exacerbation of chronic obstructive pulmonary
disease. However, larger clinical studies with asymptomatic controls are required to better define
the significance of HRV-C infection in the adult population. On the basis of VP4 sequence
analysis, a potential distinct subgroup within HRV-C has also been identified, although more
complete genome sequences are needed to better define the genetic diversity of HRV-C.
Introduction
Human rhinoviruses (HRVs) are the most frequent causes of
acute respiratory tract infections (RTIs). They are small,
nonenveloped, single-stranded, positive-sense, RNA viruses
that are now classified within the genus Enterovirus of the
eight genera belonging to the family Picornaviridae. Tradi-
tionally, they have been associated only with mild upper
respiratory tract infections (URTIs). Most ‘classical’ HRVs
have a relatively low optimal temperature for growth (331C),
reflecting their adaptation to the human nasopharynx
and association with URTIs. However, recent studies have
shown that they are increasingly associated with more
severe diseases such as pneumoniaFespecially in infants,
the elderly and immunocompromised patients.1–3 ‘Classical’
HRVs consist of more than 100 distinct serotypes, which
appear to correlate with VP1 gene sequences.4 The different
serotypes can be further classified according to receptor
specificity, antiviral susceptibility and nucleotide sequence
identities.4 On the basis of VP4/VP2 gene sequence analysis,
all serotypes except HRV87 were classified into two species,
HRV-A with 74 serotypes, and HRV-B with 25 serotypes.5–8
Because the etiological agents of a significant proportion
of RTIs remain unknown,9,10 intensive research efforts
were carried out in the past few years to identify novel
respiratory pathogens that could be responsible. Apart from
the recent discovery of human metapneumovirus,11 severe
acute respiratory syndrome coronavirus,12 human corona-
virus NL63 (HCoV-NL63),13,14 human coronavirus HKU1
(HCoV-HKU1)15–18 and human bocavirus (HBoV),18–20
several research groups have previously reported the detec-
tion of novel HRV genotypes in respiratory tract specimens
from patients in the United States, Australia and China.21–25
Analysis of the complete genome sequences suggested
that these newly identified HRV genotypes belonged to a
potentially novel HRV species, human rhinovirus C (HRV-C),
with genome features distinct from HRV-A and HRV-B.24,26
HRVs closely related to HRV-C have subsequently been
found in patients from various countries, suggesting that
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these viruses are circulating worldwide and represent an
important cause of respiratory disease.25,27–41 In this review,
we summarize current knowledge of the epidemiology,
clinical features, genome features, molecular diagnosis and
genetic diversity of this novel HRV species.
Methods
Keywords including ‘rhinovirus’, ‘new’, ‘novel’, ‘HRV’ and
‘HRV-C’ were used in MEDLINE searches. The search results
were then manually screened to include literature on the
newly described HRV-C species or related strains.
Human rhinovirus C: discovery of a novel HRV species
In 2006, new rhinovirus genotypes were identified in
respiratory samples collected from patients in Queensland
and New York City.21,22 Because only partial VP4/VP2
sequences were available, the phylogenetic positions of these
new genotypes could not be ascertained then, and the strains
found in New York were designated HRV-NY. After complete
polyprotein gene sequencing a Queensland strain, desig-
nated HRV-QPM, was classified as a subgroup of HRV-A,
HRV-A2.23 In a previous study of HBoV infections in children
admitted to hospital,24 we also identified the presence of
HRV sequences that did not cluster with either HRV-A or
HRV-B species. Upon VP4 sequence analysis, these HRV
strains from New York, Queensland and Hong Kong fell into
a distinct cluster away from HRV-A and HRV-B, suggesting
that they represent a novel clade of HRVs. To better ascertain
their phylogenetic position and genome structure, we
carried out complete genome sequence analysis on three of
strains found by us, which revealed distinct genome features
supporting the classification of HRV-C as a separate species.24
As a result of limited sequence data available in earlier
studies, it was uncertain whether HRV-Cs represent only
novel genotypes or a sublineage within HRV-A, so these
virus strains were given different names (Table 1). However,
based on the currently available sequence data, HRV-C
is now proposed by the International Committee on
Taxonomy of Viruses (http://talk.ictvonline.org/media/p/
1201.aspx) as a new HRV species in the genus Enterovirus,
family Picornaviridae, order Picornavirales.
Epidemiology of HRV-C
Within three years since its first descriptions up to July 2009,
20 reports have been published describing the detection
of HRV-C in clinical samples of patients from countries in
Africa, Asia, Australia, Europe and America.21–25,27–41 Most
reports were based on respiratory samples taken from
patients with respiratory illness, with the reported preva-
lence of HRV-C ranging from 1.4 to 30.9% among tested
specimens. The difference in reported prevalence among
available studies is likely due to differences among patient
groups, specimen types and detection methods. Neverthe-
less, in most studies, HRV-C was detected in 45% of tested
specimens, suggesting an important role for the virus in RTIs
worldwide. Apart from sporadic infections, HRV-C probably
causes frequent outbreaks of respiratory illness in the
community and institutions. In our recent study, 12% of
cases of HRV-C infections were acquired during institutio-
nalization or admission to hospital.40 In incidents of
community-acquired illness, clusters of cases were linked to
the same strains of HRV-C within a short period of time and
there were frequent reports of contact among patients who
suffered from a similar illness.40
HRV-C appears to dominate among HRVs implicated in
human RTIs. Among the 26 nasopharyngeal aspirates (NPAs)
tested positive for HRV in our earlier study, 21 (81%)
belonged to HRV-C whereas five (19%) belonged to HRV-A;
HRV-B was not detected.24 In a recent study that included
220 NPAs positive for HRV, HRV-A was the most prevalent
species (50%), whereas HRV-C accounted for 41% and HRV-B
accounted for 8% of respiratory samples, suggesting that
HRV-A and HRV-C are more prevalent than HRV-B in Hong
Kong.40 In a number of studies in other countries, HRV-C
was found to be the predominant HRV species as it was
identified in 50–73% of tested samples, whereas HRV-B was
the least common species.21,22,27,39 However, the sensitivity
of the various assays used to spot different HRV species was
uncertain in many of the studies. In a study from the United
States, HRV-C was suspected as the cause of almost half of all
HRV-associated hospitalizations.34 On the basis of these
data, it can be concluded that this newly described HRV
species likely contributes to a significant proportion of
HRV infections that were unrecognized in the past.
Human rhinoviruses are known as a cause of epidemics in
early fall and late spring. In some studies, which include
clinical specimens collected throughout the year, HRV-C
appears to show seasonal patterns of infection. In
Hong Kong, a subtropical city, infections caused by HRVs,
including HRV-C, occur throughout the year, although
a higher incidence has been observed during the fall and
winter months.24,40 In a study from Beijing, HRV-C was
also detected in specimens collected in the fall (October–
December) but not during summer (July–September).33
A recent study from Thailand has shown that HRV-C can
be found throughout the year but predominates in the rainy
season,39 whereas in South Korea it has been detected mostly
in the spring.37 As for Australia, HRV-C appeared to reach
peak prevalence in the winter, but was also detected in spring
and summer.23 In a study from the United States, HRV-C
prevalence peaked in October (early fall).34 Therefore, it
appears that HRV-C shows seasonality, with peaks in fall or
winter in most temperate or subtropical countries, but a
possible peak incidence during the rainy season in the
tropics. As peaks in fall and winter have also been observed
in HRV-A and HRV-B infections, infections with these
rhinoviruses may show similar seasonality.40 We recently
reported an apparent alternating disease activity between
HRV-A and HRV-C, although studies of longer duration are
required to confirm this phenomenon, which may be due to
viral interference or cross-serological protection similar to
that seen with human parainfluenza viruses.40,42
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Despite the high prevalence of HRV-C and other HRVs
detected in various studies, it is important to note that few
data were available on the incidence of co-infections. In our
earliest study, HRV-C strains were identified during a search
for co-pathogens in HBoV infections.24 In a recent study that
involved patients from Thailand, the frequency of co-
infection with HRV-C and other respiratory viral pathogens
Fincluding HBoV, adenovirus, polyomavirus, influenza
virus, parainfluenza virus, respiratory syncytial virus and
human metapneumovirusFwas as high as 40%.39 In a
recent report from Shanghai, co-infection by HRV-A and
HRV-B or HRV-C was also observed.41 In fact, co-detection of
multiple viruses in respiratory infections has been increas-
ingly frequent as a result of the availability of more accurate
detection assays, and the development of microarrays and
multiplex detection assays.25,43–48 The concept of virus-
associated RTIs is likely to be revolutionized in the near
future, and the role of respiratory viruses will probably be
redefined.
Clinical features of HRV-C infections
HRV-C is now known to be associated with both mild URTIs
and more severe lower respiratory tract infections (LRTIs) in
children and adults. In the earliest studies, HRV-C was
detected in patients with influenza-like illness, infants with
bronchiolitis and children admitted to hospital for acute
respiratory illness.21–24 Although children with HRV-C
infections often presented with URTIs, complications were
not uncommon and included asthmatic exacerbations or
febrile wheeze triggered by the virus infection.23,24,34,35,39,40
A study from the United States found that children with
HRV-Cs were more likely than those with HRV-As to have a
diagnosis of asthma on discharge from hospital.34 In a recent
study by us, it was found that wheezing episodes were also
more common in patients infected with HRV-C and HRV-A
than those who had HRV-B infections.40 HRV-C has been
detected frequently in children with LRTIs including bron-
chitis, bronchiolitis and pneumonia.23,24,27,33,37,39,40 This
suggests that these viruses are also associated with more
severe respiratory disease. However, a recent report did not
find that HRV-C strains had greater clinical impact than
HRV-A or HRV-B on respiratory compromise in children with
LRTI.41 HRV-C has also been detected in children with acute
otitis media and acute sinusitis, in addition to RTIs.24,40 This
fact is supported in a recent study in Finland, which reported
the presence of the virus in the middle-ear fluid of young
children with acute otitis media.31 In a recent case report
from Switzerland, HRV-C was detected in the bronchoalveo-
lar lavage specimen, pericardial fluid, plasma and stool of a
14-month-old boy with an LRTI complicated by severe
pericarditis.36 These reports suggest that the new HRV
species can cause extrarespiratory and systemic infection,
with serious complications such as pericarditis.
The significance of HRV-C infection in the adult popula-
tion is less well studied. This is probably due to the lower
hospitalization and sampling rate for respiratory illness in
adults, and the lack of clinical data even in studies where
samples from adults are included.21,22,29,32 In reports where a
brief clinical diagnosis was provided, HRV-C was detected in
adults with exacerbation of chronic obstructive pulmonary
disease,23 asthma,25 URTIs and LRTIs.38 In a recent study by
us that aimed to better define the role of HRV-C in adult
respiratory illness, eight (62%) of the 13 adults with HRV-C
infections had pneumonia, a rate significantly higher than
that observed with HRV-A infections in the study popula-
tion.40 The other four patients presented with URTI and one
with exacerbation of chronic obstructive pulmonary dis-
ease.40 Further clinical studies that involve more adult
patients and asymptomatic controls are required to examine
whether HRV-C could be more virulent than other HRVs.
Distinct genome features of HRV-C
Genomic studies on HRVs have been limited until recently,
with only five HRV-A and one HRV-B genomes published
before 2007. Although 97 and 31 complete genome
sequences are now available for HRV-A and HRV-B, respec-
tively,49–58 only seven genomes or complete polyprotein
coding regions of HRV-C have been sequenced up to the time
of writing this article: three from Hong Kong strains (HRV-C
024, 025 and 026), two from California (NAT001 and
NAT045), one from New York (NY1078) and one from
Australia (HRV-QPM).23–25,49 The genome organization of
HRV-C is typical of Picornaviridae, comprising a 50-noncoding
region (50-NCR), a single open reading frame encoding a
single polyprotein and a 30-NCR before a polyadenylated
tract. However, the genome of HRV-C was the shortest
among other reported HRVs and HEVs, a result of several
deletions.23,24 Although the P1 region of HRV-C possessed
higher amino-acid identities to that of HRV-A than to the P1
region of HRV-B, the P3 region possessed higher amino-acid
identities to that of HRV-B than to the P3 region of HRV-A.
The predicted amino-acid sequence of the HRV-C poly-
protein shared only 51–52% and 47–48% with that of HRV-A
and HRV-B, respectively.23,24 Phylogenetic analysis of the
50-NCR region and the predicted proteins revealed that
HRV-C strains formed a distinct cluster away from HRV-A
and HRV-B, which indicates that they represent a novel
HRV species. Although HRV-C is a newly described HRV
species, molecular dating analysis using sequences of the
VP4/2 coding regions indicated that these viruses have been
circulating for at least 250 years, with an estimated evolu-
tionary rate of 6.6104 substitutions per site per year.29
HRV-C shows several distinct genomic features that further
support its classification as a separate species. First, a unique
putative cleavage site was identified between VP4 and VP2.24
Second, major insertions and deletions were observed in
VP1, which is shorter than that of other HRVs, especially in
regions that were important for neutralization in HRV-A and
HRV-B.23,24 Third, the conserved amino-acid residues within
VP1 that determine receptor binding of HRV-A and HRV-B
were found to have frequent substitutions in HRV-C.24 Using
structural homology modeling, it was also found the VP1 of
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Figure 1 Phylogenetic tree of the VP4 region of HRV-C strains detected in different countries, showing the presence of a potential distinct subgroup. 201 nucleotide
positions in each VP4 region were included in the analysis. The tree was constructed by a neighbor-joining method and bootstrap values were calculated from 1000 trees. The
scale bar indicates the estimated number of substitutions per 50 nucleotides. Strains from Hong Kong are indicated by HRV-C/HK/strain no./year of detection. The GenBank
accession numbers of the previously published sequences are as follows: HRV-QPM, EF186077; HRV89, A10937; HRV14, NC_001490; DK-1, EU697851; DK-30, EU697837;
DK-33, EU697833; HC85215, EU697846; HC90837, EU697856; HC90841, EU697863; hRVLz118, EU822834; hRVLz123, EU822836; hRVLz127, EU822838; hRVLz144,
EU822840; hRVLz148, EU822841; hRVLz163, EU822842; hRVLz167, EU822843; hRVLz185, EU822847; hRVLz269, EU822856; hRVLz333, EU822869; hRVLz383, EU822878;
hRVLz390, EU822879; IN-26, EU697865; IN-35, EU697845; IN-36, EU697839; HRV 7316563, EU697850; NY-003, DQ875929; NY-028, DQ875931; NY-041, DQ875921;
NY-042, DQ875926; NY-060, DQ875928; NY-063, DQ975924; SA365412, EU697852; SA440023, EU697829; SA442718, EU697828; SO4302, EU697869; SO4450,
EU697835; SO4463, EU697854; SO4868, EU697854; NAT001, EF077252; NAT045, EF077253; NAT083, EF077264; QPID03-0035, EU155152; QPID03-0033, EU155153;
QPID03-0028, EU155154; QPID04-0006, EU155158; HRVC 102307, EU687518; HRVC 102507, EU687523; HRVC 101507, EU687515; HRVC 120107, EU687527; HRVC
102207, EU687516; HRVC 110507, EU687522; HRVC 103007, EU687519; HRVC 112007, EU687525; HRVC 103107, EU687520; HRVC 102107, EU687517; HRVC 111007,
EU687524; HRVC 120407, EU687528; Pico tu304, EU081791; Pico tu306, EU081793; Pico tu403, EU081795; Pico 06-445, EU081796; Pico tu68b, EU081797; Pico g2-10,
EU081798; Pico g2-11, EU081799; Pico 06-20, EU081800; Pico g2-12, EU081801; Pico g2-25, EU081802; Pico 06-447b, EU081806; Pico 06-230, EU081807; Pico 06-582,
EU081809; Pico g2-3, EU081810; Pico 06-646, EU081811; Pico g2-8, EU081812; Pico 06-738, EU081813; Pico tu174, EU081814; Pico 06-225, EU081815.
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HRV-C possesses structural disparities within sites for
receptor binding of HRV-A and HRV-B.26 These suggest
that HRV-C may use a different cellular receptor, reflected
in its failure to grow in traditional cell cultures. In addition,
a novel distinct cis-acting replication element located in
the VP2 region has been identified in HRV-C, supporting
its classification as a separate species.59 By completing the
genome sequences for all known HRV serotypes, a recent
study also confirmed species-specific sequence and RNA
structure elements that differentiate HRV-C from HRV-A
and HRV-B.49 Although HRV-A strains are currently suscep-
tible to the antiviral drug pleconaril, analysis of the
genome sequence data suggested that HRV-C may be
resistant to this drug, in view of the presence of Phe152
and Thr191 in the VP1 of some reported strains.
23,24 However,
this would need to be verified by in vitro assays when
cell culture systems are established. The use of reverse
genetic approaches may overcome the difficulties in
isolating HRV-C.
Molecular detection and genetic diversity of HRV-C
50-NCR and VP4/VP2 regions were the most commonly used
targets for detection of HRV-C, although the 50-NCR region
appears to be more sensitive for HRV detection.32,37 In one
study, VP4/VP2 RT-PCR failed to detect all 24 samples with
HRVs using cDNA templates identical to those used for
50-NCR RT-PCR.32 However, 50-NCR sequence is not suitable
for assignment of phylogenetic relationships.22,60 To better
determine the prevalence of HRVs in respiratory specimens,
it is important that 50-NCR regions should be used for
detection and VP4/VP2 or VP1 sequences for more accurate
species identification. Because VP4 is a highly conserved
protein, the use of amino-acid sequences may underestimate
the diversity and number of HRV strains as compared with
nucleotides sequences. However, it remains to be determined
which should be the valid approach for representation of
different HRV-C strains.
In addition to the commonly used PCR methodology,
other molecular detection methods have also been used to
detect HRV-C viruses. In a study from the United States,
Virochip was used for virus detection.25 Virochip is a DNA
microarray that contains the most conserved sequences of all
known viruses identified in humans, animals, plants and
microbes.46 This method can detect new members of known
virus families by cross-hybridization, which offers a signi-
ficant advantage compared to PCR-based methods.46,47 In
another study, also from the United States, respiratory
multicode assay (RMA) was used to detect viruses.28 RMA is
a high-throughput, multiplex PCR-microsphere flow cyto-
metry assay designed for comprehensive detection of
common respiratory viruses and consists of five main steps,
all of which take place in the same microwell.48 Apart from
having the capacity to detect new viruses, these assays also
allow simultaneous detection of multiple viruses from the
same sample, which may provide better information on rates
of co-infection.
Real-time RT-PCR has been used to measure the viral load
of HRV-C in clinical specimens. In a study from Italy, the
median peak viral load of 28 patients with HRV-C infection
was 4.5106 RNA copies per ml in NPA, which is slightly
higher than that seen in 45 patients with HRV-A infection
(2.2106 RNA copies per ml) and in 12 patients with HRV-B
infection (1.6105 RNA copies per ml); however, the
difference was not statistically significant.38 In a case report
from Switzerland about HRV-C LRTI complicated by pericar-
ditis, the viral load was significantly higher in the broncho-
alveolar lavage specimen compared with that in plasma and
stool specimens, consistent with the virus’ association with
RTIs.36
Currently, data on serotype recurrence of HRVs and their
seasonal distribution are very limited. In our recent report,
recurrent infections by different HRV strains of the same
patient were observed within a short period of time.40
Whereas numerous HRV strains belonging to the HRV-C
species have been identified, a huge genetic diversity was
detected among strains within the species, and this may
help the virus evade immune protection. In our study, the
VP4 sequences of the identified HRV-C strains showed
67.2–82.1% nucleotide identities to that of our reference
HRV-C strain 024.40 By phylogenetic analysis of available
VP4 sequences of HRV-C, we also identified a potential
distinct subgroup of strains within HRV-C (Figure 1).40
Interestingly, HRV-C strains presenting divergent 50-NCR
sequences were also observed in the past,28,61 and a recent
report proposed to subdivide HRV-C in two distinct sub-
species based on 50-NCR regions.41 However, as only 50-NCR
regions were studied for some of the previously reported
strains, it remains to be determined if these subspecies
correspond to the subgroup we identified based on VP4
sequences. More complete genome sequences of strains from
these potential subgroups of HRV-C and successful isolation
of different HRV-C genotypes would be required to ascertain
the existence of subspecies, and to study their genetic
diversity and cross-serological reactivity.
Concluding remarks
Because HRVs were historically considered to have little
health impact and clinical significance, the possible
existence of novel species and the relative importance and
classification of the different species have been poorly
investigated.62 Recent studies have shown that in fact HRVs
are more important than respiratory syncytial virus as a
cause of respiratory virus-associated hospital admissions, and
as predictors of recurrent wheezing in children in large
cohorts.2,63 The discovery of HRV-C as a novel species with
diverse genotypes, and its prevalence in human respiratory
samples, has ushered a new era in HRV research, by
uncovering viruses that account for a significant proportion
of previously undiagnosed respiratory illness. However, our
understanding of this novel HRV species has been hindered
to date by a failure to culture these viruses in cell lines.
Therefore, further studies on HRV-C are required to better
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understand the viruses’ genetic diversity, mechanism of
immune evasion, virulence and antiviral susceptibilities. We
suggest that these studies should focus on analysis of more
HRV-C genome sequences, pathogenesis and the develop-
ment of culture systems.
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